Skip to Main Content

Paper Details

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Elife
29
2022
Author NameAffiliation
Kimberly Meade-WhiteNational Institute of Allergy and Infectious Diseases, National Institutes of Health
Michael GaleCenter for Innate Immunity and Immune Disease, University of Washington School of Medicine
  • 1 - 2

Datasets

Release 1.2